This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Vilá, L M Articles by Vilá, S Search for Related Content PubMed PubMed Citation Articles by Vilá, L M Articles by Vilá, S Social Bookmarking                   What's this?

Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus

A M Mayor

A H Valentín

M García-Soberal

S Vilá

Department of Internal Medicine, Division of Rheumatology, Universidad Central del Caribe School of Medicine, Bayamoín, Puerto Rico

To gain a better understanding of systemic lupus erythematosus (SLE) in Puerto Ricans we studied the clinical and serologic manifestations in a cohort of 134 patients. The female to male ratio was 18: 1. Mean age at diagnosis was 32 12 y. The mean duration of disease and follow-up were 7.4 6.0 and 5.8 6.0 years respectively. Mortality was 3%. Photosensitivity (76.9%) and malar rash (71.9%) were the most common clinical manifestations. Arthritis was observed in 67.5% of patients. Anemia was seen in 67.2% of patients, but only 12.7% had autoimmune hemolytic anemia. Leukopenia (41.8%) and lymphopenia (64.9%) were also common. Serositis was observed in only 28%. Severe kidney damage such as nephrotic syndrome (14.2%) or renal failure (4%) was infrequent. Cardiovascular (12.7%) and neurologic (9.0%) manifestations were also uncommon. Antinuclear antibodies (ANA) were detected in 93.3%, anti-dsDNA antibodies in 54.5%, anti-Ro antibodies in 30.1% and anti-La antibodies in 14.2%. Low C3 and low C4 were observed in 38.3% and 35.7% respectively. This study suggests that Puerto Ricans with SLE present a mild form of disease predominantly manifested by cutaneous, musculoskeletal and hematologic involvement, but low prevalence of major organ damage and low mortality.

Key Words: systemic lupus erythematosus • autoantibody • ethnicity • Latin-American • Puerto Ricans

Lupus, Vol. 8, No. 4, 279-286 (1999)
DOI: 10.1191/096120399678847803


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Nazarinia, F Ghaffarpasand, A Shamsdin, A. Karimi, N Abbasi, and A Amiri Systemic lupus erythematosus in the Fars Province of Iran Lupus, March 1, 2008; 17(3): 221 - 227. [Abstract] [PDF]

				H. Al-Rayes, R. Al-Swailem, M. Arfin, S. Sobki, S. Rizvi, and M. Tariq Lupus Around the World: Systemic lupus erythematosus and infections: a retrospective study in Saudis Lupus, September 1, 2007; 16(9): 755 - 763. [Abstract] [PDF]

				L M Vila, M J Molina, A M Mayor, R A Peredo, M L Santaella, and S Vila Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus Lupus, December 1, 2006; 15(12): 892 - 898. [Abstract] [PDF]

				S J Walsh and A Gilchrist Geographical clustering of mortality from systemic lupus erythematosus in the United States: contributions of poverty, Hispanic ethnicity and solar radiation Lupus, October 1, 2006; 15(10): 662 - 670. [Abstract] [PDF]

				M A Rabbani, B K Siddiqui, M H Tahir, B Ahmad, A Shamim, S M. Shah, and A Ahmad Systemic lupus erythematosus in Pakistan Lupus, October 1, 2004; 13(10): 820 - 825. [Abstract] [PDF]

				L. M. Vila, G. S. Alarcon, G. McGwin Jr, A. W. Friedman, B. A. Baethge, H. M. Bastian, B. J. Fessler, and J. D. Reveille Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations Rheumatology, March 1, 2004; 43(3): 358 - 363. [Abstract] [Full Text] [PDF]

				P V Voulgari, P Katsimbri, Y Alamanos, and A A Drosos Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature Lupus, November 1, 2002; 11(11): 722 - 729. [Abstract] [PDF]

				G S Alarcon, G McGwin Jr, M Petri, J D Reveille, R Ramsey-Goldman, R P Kimberly, and the PROFILE Study Group Baseline characteristics of a multiethnic lupus cohort: PROFILE Lupus, February 1, 2002; 11(2): 95 - 101. [Abstract] [PDF]

				L. Balluz, R. Philen, L. Ortega, C. Rosales, J. Brock, D. Barr, and S. Kieszak Investigation of Systemic Lupus Erythematosus in Nogales, Arizona Am. J. Epidemiol., December 1, 2001; 154(11): 1029 - 1036. [Abstract] [Full Text] [PDF]

				S J Walsh and L M Dechello Geographical variation in mortality from systemic lupus erythematosus in the United States Lupus, September 1, 2001; 10(9): 637 - 646. [Abstract] [PDF]

				L. Vila, A. Mayor, A. Valent, M Garc, and S Vila Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus Lupus, February 1, 2000; 9(2): 110 - 115. [Abstract] [PDF]